8CYI
Cryo-EM structures and computational analysis for enhanced potency in MTA-synergic inhibition of human protein arginine methyltransferase 5
Summary for 8CYI
Entry DOI | 10.2210/pdb8cyi/pdb |
EMDB information | 27078 |
Descriptor | Protein arginine N-methyltransferase 5, Methylosome protein 50, N-[(2-aminoquinolin-7-yl)methyl]-9-(2-hydroxyethyl)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide, ... (4 entities in total) |
Functional Keywords | prmt5, protein arginine methyl transferase, mta-inhibitor synergy, cryo-em structure-based drug design, computational analysis, catalytic mechanism, drug discovery, docking analysis, oncoprotein, oncoprotein-transferase complex, oncoprotein/transferase |
Biological source | Homo sapiens (human) More |
Total number of polymer chains | 2 |
Total formula weight | 106704.71 |
Authors | Yadav, G.P.,Wei, Z.,Xiaozhi, Y.,Chenglong, L.,Jiang, Q. (deposition date: 2022-05-23, release date: 2023-04-12) |
Primary citation | Zhou, W.,Yadav, G.P.,Yang, X.,Qin, F.,Li, C.,Jiang, Q.X. Cryo-EM structure-based selection of computed ligand poses enables design of MTA-synergic PRMT5 inhibitors of better potency. Commun Biol, 5:1054-1054, 2022 Cited by PubMed: 36192627DOI: 10.1038/s42003-022-03991-9 PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (3.14 Å) |
Structure validation
Download full validation report